Richard C. Cilento
Independent DirectorMr. Richard C. Cilento, MBA, Jr., also known as Rich, serves as an Independent Director at FibroBiologics, Inc. (Formerly, FibroBiologics LLC) since April 2021. He serves as Chief Executive Officer at GlycosBio Asia Sdn Bhd. Mr. Cilento is the founder, Chairperson of the board of directors and Chief Executive Officer of GlycosBio Inc. He serves as a Venture Advisor at Mercury Fund. He serves as an Advisor to a number of small businesses. He has been Chairman of Advisory Board at Insite360 (formerly known as FuelQuest, Inc.)., since October 2008. Mr. Cilento serves as Director at GlycosBio Asia Sdn Bhd. He serves as Advisory Board Member at Mgi2 Inc. Mr. Cilento was the founder, President and Chief Executive Officer of FuelQuest, Inc., a provider of information technology, supply chain management and tax automation technologies, which was acquired by Saracen Energy Advisors LP in May 2007. Prior to the firm, he was a Co-Founder and Principal at The Bollard Group. Prior to co-founding the firm, Mr. Cilento held senior-management positions at Xerox Corp., where he served as a Vice President of Strategic Services. Prior to that, he was the Vice President of Corporate Services for XLConnect Solutions, where he served as the lead technologist for advanced systems and supported the organization through its initial public offering and its eventual merger with Xerox. Mr. Cilento began his career at NASA, where he was a Space Shuttle Flight Controller. He served as Director at Momentum Biofuels, Inc., from 2006 to February 2, 2009. He served as Director at The Bollard Group, LLC. Mr. Cilento received national business honors in 2006, winning the Ernst and Young Entrepreneur of the Year Award for Energy Technology. He has extensive experience in leadership and technical roles in energy, biotechnology and information technology companies. At NASA, he and his team built space shuttle flight plans for the U.S. Department of Defense Star Wars program and a diverse set of government-funded technology and life science experimentation. He was a lead engineer who designed and planned the space station assembly sequences for the construction of the International Space Station. His business experience across a broad set of technical industries and executive-level knowledge of capital markets, including venture capital, private equity and public markets, qualifies him to serve on the Board. Mr. Cilento holds a BS degree in Aeronautical and Astronomical Engineering from the University of Illinois and an MBA at the University of Houston, Clear Lake.
Positions
- Company NameFibroBiologics, Inc.Stock CodeFBLGPositionIndependent Director
